Rio Biopharmaceuticals Inc
General
Total Cases3
Active Cases--
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/13/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2; 10,335,462 B2; 8,129,343 B2; 8,920,383 B2; 9,457,154 B2; 9,775,953 B2. (Attachments: # [1] Stipulation of Dismissal) (mws) (Entered: 12/13/2024) | |
| 12/13/24 | SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) | |
| 12/13/24 | Remark: CASE CLOSED per [371] STIPULATION of Dismissal, as all defendants in the case have been terminated. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC (mws) (Entered: 12/13/2024) | |
| 12/12/24 | STIPULATION of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences by Novo Nordisk Inc., Novo Nordisk A/S. (Egan, Brian) (Entered: 12/12/2024) | |
| 12/06/24 | SO ORDERED, re (369 in 1:22-cv-00294-CFC-EGT, 420 in 1:22-md-03038-CFC-EGT) MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (kmd) (Entered: 12/06/2024) | |
| 12/06/24 | MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Novo Nordisk Inc., Novo Nordisk A/S. Motions referred to Eleanor G. Tennyson.(Murray, Travis) (Entered: 12/06/2024) | |
| 12/03/24 | ORDER re (367 in 1:22-cv-00294-CFC-EGT, 418 in 1:22-md-03038-CFC-EGT) Stipulation of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice). Party EMS S/A and Rio Biopharmaceuticals, Inc. terminated. Signed by Judge Colm F. Connolly on 12/3/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 12/03/2024) | |
| 12/03/24 | STIPULATION of Dismissal (as to Defendants Rio Biopharmaceuticals, Inc. and EMS S/A - without prejudice) by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 12/03/2024) | |
| 11/18/24 | ORAL ORDER: On or before 11/25/2024, the parties shall jointly submit a glossary of terms and names for the court reporter. Ordered by Judge Colm F. Connolly on 11/18/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT(mws) (Entered: 11/18/2024) | |
| 11/18/24 | ORAL ORDER: The Bench Trial originally set to begin 12/9/2024 has been rescheduled. A four-day Bench Trial is scheduled to begin 12/16/2024 at 8:30a.m. before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 11/18/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT (mws) (Entered: 11/18/2024) |